연구성과로 돌아가기
2023 연구자 정보 (425 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Hyun-Kuk (Kim, HK) |
Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Pulmonol, Busan, South Korea Inje Univ, Div Pulmonol, Dept Internal Med, Haeundae Paik Hosp, Busan, South Korea |
ISA-2120-2023 Kim, Jong-Yeup |
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Kim, Jin Woo (Kim, JW) |
Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Uijongbu, South Korea |
|
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Kim, Jusang (Kim, J) |
Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Incheon, South Korea Catholic Univ Korea, Incheon St Marys Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Incheon, South Korea |
AAB-3748-2019 KIM, JUSANG |
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Ko, Yousang (Ko, Y) |
Kangdong Sacred Heart Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Seoul, South Korea |
|
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Koh, Seok-Joo (Koh, SJ) |
교신저자 |
Kyungpook Natl Univ, Sch Comp Sci & Engn, 80 Daehak Ro, Daegu 41566, South Korea Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu, South Korea Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea |
|
0000-0003-3429-2040 Koh, Seok-Joo |
[JCR상위 11.4] Use of QUIC for CoAP transport in IoT networks [JCR상위 15.8] Performance evaluation of AMQP over QUIC in the internet-of-thing networks [JCR상위 44.3] Zero Energy IoT Devices in Smart Cities Using RF Energy Harvesting [JCR상위 14.4] Use of QUIC for AMQP in IoT networks |
SCIE | 11.4 |
COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS COMPUTER SCIENCE, INFORMATION SYSTEMS COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;PHYSICS, APPLIED COMPUTER SCIENCE, HARDWARE & ARCHITECTURE;COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS |
sjkoh@knu.ac.kr; mgohar.buic@bahria.edu.pk; mgohar.buic@bahria.edu.pk;sjkoh@knu.ac.kr; moneebgohar@gmail.com; |
|
|
Laget, J. -M (Laget, JM) |
Thomas Jefferson Natl Accelerator Facil, Newport News, VA USA |
|
|
[JCR상위 11.4] A multidimensional study of the structure function ratio σLT''/σ0 from hard exclusive π± electro-production off protons in the GPD regime | SCIE | 11.4 | ASTRONOMY & ASTROPHYSICS;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS | stefan.diehl@exp2.physik.uni-giessen.de; | ||
|
Lee, Heayon (Lee, H) |
Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Seoul, South Korea Catholic Univ Korea, Eunpyeong St Marys Hosp, Div Pulm Crit Care & Sleep Med, Dept Internal Med, Seoul, South Korea |
AAB-9799-2022 Lee, Yoojin |
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Lee, Hyun-Kyung (Lee, HK) |
Inje Univ, Busan Paik Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Busan, South Korea Inje Univ, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Busan Paik Hosp, Busan, South Korea |
|
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Lee, Jae Chul (Lee, JC) |
Univ Ulsan, Asan Med Ctr, Internal Med, Coll Med, Seoul, South Korea |
|
|
[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Lee, Ji-Young (Lee, JY) |
Univ Ulsan, Asan Med Ctr, Med Sci, Coll Med, Seoul, South Korea Univ Ulsan, Asan Med Inst Convergence Sci & Technol, Asan Med Ctr,Coll Med, Dept Med Sci, Seoul 05505, South Korea |
|
|
[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial [JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial |
SCIE | 11.4 |
RESPIRATORY SYSTEM CELL BIOLOGY |
ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; | ||
|
Lee, Sung Yong (Lee, SY) |
Korea Univ, Internal Med, Guro Hosp, Seoul, South Korea Korea Univ, Guro Hosp, Dept Internal Med, Coll Med, Seoul, South Korea Korea Univ, Guro Hosp, Dept Internal Med, Seoul 08308, South Korea Korea Univ Guro Hosp, Dept Internal Med cine, Div Pulm Allergy & Crit Care Med, Seoul, South Korea Korea Univ, Div Pulmonol Allergy & Crit Care Med, Dept Internal Med, Guro Hosp, Seoul, South Korea Korea Univ, Guro Hosp, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Seoul, South Korea |
A-3892-2015 ADE-2110-2022 Lee, Sang-Jun Lee, Joo Yong |
0000-0002-8693-5792 LEE, SUNG YONG |
[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial [JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR [JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial [JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data [JCR상위 28.4] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer [JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors [JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study |
SCIE | 1.5 |
RESPIRATORY SYSTEM ONCOLOGY;RESPIRATORY SYSTEM CELL BIOLOGY ONCOLOGY |
droij@jnu.ac.kr; ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; jangtw22@hanmail.net; jclee@amc.seoul.kr; jangtw22@hanmail.com; |
||
|
Lee, Sunyoung (Lee, S) |
Inje Univ, Ctr Personalized Precis Med TB CPMTb, Coll Med, Busan, South Korea |
|
|
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort | SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
Long, Nguyen Phuoc (Long, NP) |
Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan, South Korea Inje Univ, Coll Med, Ctr Personalized Precis Med TB, Busan, South Korea |
U-4162-2019 Long, Nguyen Phuoc |
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study | SCIE | 11.4 | RESPIRATORY SYSTEM | |||
|
MacGregor, I. . J. . D. (MacGregor, IJD) |
Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland |
D-4072-2011 MacGregor, Ian |
|
[JCR상위 11.4] A multidimensional study of the structure function ratio σLT''/σ0 from hard exclusive π± electro-production off protons in the GPD regime | SCIE | 11.4 | ASTRONOMY & ASTROPHYSICS;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS | stefan.diehl@exp2.physik.uni-giessen.de; | ||
|
Min, Jinsoo (Min, J) |
Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Seoul, South Korea Catholic Univ Korea, Seoul St Marys Hosp, Div Pulm Allergy & Crit Care Med, Dept Internal Med, Seoul, South Korea |
D-5181-2018 Min, Jinsoo |
|
[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study [JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort |
SCIE | 11.4 | RESPIRATORY SYSTEM |
페이지 이동: